Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 6592820, 10 pages
https://doi.org/10.1155/2017/6592820
Review Article

Snake Venom PLA2, a Promising Target for Broad-Spectrum Antivenom Drug Development

Department of Biochemistry, College of Basic Medical Sciences, Nanchang University, Nanchang, Jiangxi Province, China

Correspondence should be addressed to Chunhong Huang; nc.ude.ucn@gnauhhc

Huixiang Xiao and Hong Pan contributed equally to this work.

Received 5 September 2017; Accepted 30 October 2017; Published 29 November 2017

Academic Editor: Ji-Fu Wei

Copyright © 2017 Huixiang Xiao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. A. Warrell, “Snake bite,” The Lancet, vol. 375, no. 9708, pp. 77–88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J.-P. Chippaux, “Snake-bites: appraisal of the global situation,” Bulletin of the World Health Organization, vol. 76, no. 5, pp. 515–524, 1998. View at Google Scholar · View at Scopus
  3. Editorial, "Snake bite—the neglected tropical disease," Lancet, vol. 386, no. 9999, pp. 1110, 2015.
  4. J. M. Gutiérrez, R. D. G. Theakston, and D. A. Warrell, “Confronting the neglected problem of snake bite envenoming: the need for a global partnership,” PLoS Medicine, vol. 3, no. 6, pp. 0727–0731, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. H. A. De Silva, N. M. Ryan, and H. J. De Silva, “Adverse reactions to snake antivenom, and their prevention and treatment,” British Journal of Clinical Pharmacology, vol. 81, no. 3, pp. 446–452, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Gutiérrez, D. Williams, H. W. Fan, and D. A. Warrell, “Snakebite envenoming from a global perspective: towards an integrated approach,” Toxicon, vol. 56, no. 7, pp. 1223–1235, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. Q. Schiermeier, “Africa braced for snakebite crisis,” Nature, vol. 525, no. 7569, p. 299, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. D. L. Scott, “Phospholipase A2 structure and catalytic properties,” in In Venom Phospholipase A2 Enzymes: Structure, Function, and Mechanism, R. M. Kini, Ed., pp. 97–128, John Wiley, Chichester, UK, 1997. View at Google Scholar
  9. E. A. Dennis, J. Cao, Y.-H. Hsu, V. Magrioti, and G. Kokotos, “Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention,” Chemical Reviews, vol. 111, no. 10, pp. 6130–6185, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. R. H. Schaloske and E. A. Dennis, “The phospholipase A2 superfamily and its group numbering system,” Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol. 1761, no. 11, pp. 1246–1259, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. D. A. Six and E. A. Dennis, “The expanding superfamily of phospholipase A2 enzymes: classification and characterization,” Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol. 1488, no. 1-2, pp. 1–19, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Fohlman, P. Lind, and D. Eaker, “Taipoxin, an extremely potent presynaptic snake venom neurotoxin Elucidation of the primary structure of the acidic carbohydrate-containing taipoxin-subunit, a prophospholipase homolog,” FEBS Letters, vol. 84, no. 2, pp. 367–371, 1977. View at Publisher · View at Google Scholar · View at Scopus
  13. J. A. Pearson, M. I. Tyler, K. V. Retson, and M. E. H. Howden, “Studies on the subunit structure of textilotoxin, a potent presynaptic neurotoxin from the venom of the Australian common brown snake (Pseudonaja textilis). 3. The complete amino-acid sequences of all the subunits,” Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, vol. 1161, no. 2-3, pp. 223–229, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. B. R. Francis, N. Jorge Da Silva Jr., C. Seebart, L. L. Casais E Silva, J. J. Schmidt, and I. I. Kaiser, “Toxins isolated from the venom of the Brazilian coral snake (Micrurus frontalis frontalis) include hemorrhagic type phospholipases A2 and postsynaptic neurotoxins,” Toxicon, vol. 35, no. 8, pp. 1193–1203, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. R. C. De Paula, H. C. Castro, C. R. Rodrigues, P. A. Melo, and A. L. Fuly, “Structural and pharmacological features of phospholipases A2 from snake venoms,” Protein and Peptide Letters, vol. 16, no. 8, pp. 899–907, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. P. Mackessy, “Snake Venom Phospholipase A2 Enzymes,” in Handbook of Venoms and Toxins of Reptiles, S. P. Mackessy, Ed., pp. 174–195, Taylor and Francis, Boca Raton, Fla, USA, 2010. View at Google Scholar
  17. T. Petan, I. Križaj, and J. Pungerčar, “Restoration of enzymatic activity in a Ser-49 phospholipase A2 homologue decreases its Ca2+-independent membrane-damaging activity and increases its toxicity,” Biochemistry, vol. 46, no. 44, pp. 12795–12809, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. R. J. Ward, L. Chioato, A. H. C. De Oliveira, R. Ruller, and J. M. Sá, “Active-site mutagenesis of a Lys49-phospholipase A2: Biological and membrane-disrupting activities in the absence of catalysis,” Biochemical Journal, vol. 362, no. 1, pp. 89–96, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Bon, “Multicomponent neurotoxic phospholipases A2,” in Venom Phospholipase A2 Enzymes: Structure, Function, and Mechanism, R. M. Kini, Ed., pp. 269–285, John Wiley, Chichester, UK, 1997. View at Google Scholar
  20. S. P. Mackessy, “The field of reptile toxinology snakes, lizards, and their venoms,” in In Handbook of Venoms and Toxins of Reptiles, S. P. Mackessy, Ed., pp. 3–19, Taylor and Francis, Boca Raton, Fla, USA, 2010. View at Google Scholar
  21. J. J. Calvete, “Proteomics in venom research: a focus on PLA2 molecules,” Acta Chimica Slovenica, vol. 58, no. 4, pp. 629–637, 2011. View at Google Scholar
  22. D. Georgieva, R. K. Arni, and C. Betzel, “Proteome analysis of snake venom toxins: pharmacological insights,” Expert Review of Proteomics, vol. 5, no. 6, pp. 787–797, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. R. H. Ziganshin, S. I. Kovalchuk, G. P. Arapidi et al., “Quantitative proteomic analysis of vietnamese krait venoms: neurotoxins are the major components in bungarus multicinctus and phospholipases A2 in bungarus fasciatus,” Toxicon, vol. 107, pp. 197–209, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. J. M. Gutiérrez and B. Lomonte, “Phospholipases A2: unveiling the secrets of a functionally versatile group of snake venom toxins,” Toxicon, vol. 62, pp. 27–39, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. R. M. Kini, “Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes,” Toxicon, vol. 42, no. 8, pp. 827–840, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. S. C. Sampaio, S. Hyslop, M. R. M. Fontes et al., “Crotoxin: novel activities for a classic β-neurotoxin,” Toxicon, vol. 55, no. 6, pp. 1045–1060, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. A. L. C. Terra, L. S. Moreira-Dill, R. Simões-Silva et al., “Biological characterization of the amazon coral micrurus spixii snake venom: isolation of a new neurotoxic phospholipase A2,” Toxicon, vol. 103, pp. 1–11, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Lambeau, P. Ancian, J. Barhanin, and M. Lazdunski, “Cloning and expression of a membrane receptor for secretory phospholipases A2,” The Journal of Biological Chemistry, vol. 269, no. 3, pp. 1575–1578, 1994. View at Google Scholar · View at Scopus
  29. G. Lambeau, A. Schmid-Alliana, M. Lazdunski, and J. Barhanin, “Identification and purification of a very high affinity binding protein for toxic phospholipases A2 in skeletal muscle,” The Journal of Biological Chemistry, vol. 265, no. 16, pp. 9526–9532, 1990. View at Google Scholar · View at Scopus
  30. B. V. Lipps, “Isolation of subunits, α, β and γ of the complex taipoxin from the venom of Australian taipan snake (Oxyuranus s. scutellatus): characterization of β taipoxin as a potent mitogen,” Toxicon, vol. 38, no. 12, pp. 1845–1854, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Coulter, R. Harris, A. Broad et al., “The isolation and some properties of the major neurotoxic component from the venom of the common or Eastern Australian brown snake (Pseudonaja textilis),” Toxicon, vol. 21, no. 3, pp. 81–84, 1983. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Faure, V. T. Gowda, and R. C. Maroun, “Characterization of a human coagulation factor Xa-binding site on Viperidae snake venom phospholipases A2 by affinity binding studies and molecular bioinformatics,” BMC Structural Biology, vol. 7, article no. 82, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Šribar, A. Čopič, A. Pariš et al., “A high affinity acceptor for phospholipase A2 with neurotoxic activity is a calmodulin,” The Journal of Biological Chemistry, vol. 276, no. 16, pp. 12493–12496, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Šribar, N. E. Sherman, P. Prijatelj et al., “The neurotoxic phospholipase A2 associates, through a non-phosphorylated binding motif, with 14-3-3 protein γ and ε isoforms,” Biochemical and Biophysical Research Communications, vol. 302, no. 4, pp. 691–696, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Vardjan, N. E. Sherman, J. Pungerčar, J. W. Fox, F. Gubenšek, and I. Križaj, “High-molecular-mass receptors for ammodytoxin in pig are tissue-specific isoforms of M-type phospholipase A2 receptor,” Biochemical and Biophysical Research Communications, vol. 289, no. 1, pp. 143–149, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Kondo, H. Toda, K. Narita, and C.-Y. Lee, “Amino acid sequences of three β-bungarotoxins (β3-, β4-, and β5-bungarotoxins) from Bungarus multicinctus Venom. amino acid substitutions in the A chains,” The Journal of Biochemistry, vol. 91, no. 5, pp. 1531–1548, 1982. View at Publisher · View at Google Scholar · View at Scopus
  37. M. J. Sutcliffe, C. M. Dobson, and R. E. Oswald, “Solution structure of neuronal bungarotoxin determined by two-dimensional NMR spectroscopy: calculation of tertiary structure using systematic homologous model building, dynamical simulated annealing, and restrained molecular dynamics,” Biochemistry, vol. 31, no. 11, pp. 2962–2970, 1992. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Halpert and D. Eaker, “Amino acid sequence of a presynaptic neurotoxin from the venom of Notechis scutatus scutatus (Australian tiger snake),” The Journal of Biological Chemistry, vol. 250, no. 17, pp. 6990–6997, 1975. View at Google Scholar · View at Scopus
  39. B. Westerlund, P. Nordlund, U. Uhlin, D. Eaker, and H. Eklund, “The three-dimensional structure of notexin, a presynaptic neurotoxic phospholipase A2 at 2.0 Å resolution,” FEBS Letters, vol. 301, no. 2, pp. 159–164, 1992. View at Publisher · View at Google Scholar · View at Scopus
  40. I. I. Kaiser, J. M. Gutierrez, D. Plummer, S. D. Aird, and G. V. Odell, “The amino acid sequence of a myotoxic phospholipase from the venom of Bothrops asper,” Archives of Biochemistry and Biophysics, vol. 278, no. 2, pp. 319–325, 1990. View at Publisher · View at Google Scholar · View at Scopus
  41. A. M. Soares, V. M. Rodrigues, M. I. Homsi-Brandeburgo et al., “A rapid procedure for the isolation of the LYS-49 myotoxin II from bothrops moojeni (caissaca) venom: biochemical characterization, crystallization, myotoxic and edematogenic activity,” Toxicon, vol. 36, no. 3, pp. 503–514, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. J. R. Almeida, M. Lancellotti, A. M. Soares et al., “CoaTx-II, a new dimeric Lys49 phospholipase A2 from Crotalus oreganus abyssus snake venom with bactericidal potential: Insights into its structure and biological roles,” Toxicon, vol. 120, pp. 147–158, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. V. L. Bonfim, L. A. Ponce-Soto, J. C. Novello, and S. Marangoni, “Structural and functional properties of Cr 5, a new Lys49 phospholipase A2 homologue isolated from the venom of the snake Calloselasma rhodostoma,” The Protein Journal, vol. 25, no. 7-8, pp. 492–502, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. L. A. Ponce-Soto, B. Lomonte, J. M. Gutiérrez, L. Rodrigues-Simioni, J. C. Novello, and S. Marangoni, “Structural and functional properties of BaTX, a new Lys49 phospholipase A2 homologue isolated from the venom of the snake Bothrops alternatus,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1770, no. 4, pp. 585–593, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. V. L. Bonfim, L. A. Ponce-Soto, D. Martins de Souza et al., “Structural and functional characterization of myotoxin, Cr-IV 1, a phospholipase A2 D49 from the venom of the snake Calloselasma rhodostoma,” Biologicals, vol. 36, no. 3, pp. 168–176, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. I. KRIŽAJ, A. L. BIEBER, A. RITONJA, and F. GUBENšEK, “The primary structure of ammodytin L, a myotoxic phospholipase A2 homologue from Vipera ammodytes venom,” European Journal of Biochemistry, vol. 202, no. 3, pp. 1165–1168, 1991. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Sharma, J. K. Iyer, N. Shih et al., “Daboxin p, a major phospholipase A2 enzyme from the indian daboia russelii russelii venom targets factor x and factor xa for its anticoagulant activity,” PLoS ONE, vol. 11, no. 4, Article ID e0153770, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. A. K. Chakraborty, R. H. Hall, and A. C. Ghose, “Purification and characterization of a potent hemolytic toxin with phospholipase A2 activity from the venom of Indian Russell's viper,” Molecular and Cellular Biochemistry, vol. 237, no. 1-2, pp. 95–102, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. R. T. Kerns, R. M. Kini, S. Stefansson, and H. J. Evans, “Targeting of venom phospholipases: The strongly anticoagulant phospholipase A2 from Naja nigricollis venom binds to coagulation factor Xa to inhibit the prothrombinase complex,” Archives of Biochemistry and Biophysics, vol. 369, no. 1, pp. 107–113, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. R. M. Kini, “Structure-function relationships and mechanism of anticoagulant phospholipase A2 enzymes from snake venoms,” Toxicon, vol. 45, no. 8, pp. 1147–1161, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. F. J. Joubert, “Naja mossambica mossambica venom Purification, some properties and the amino acid sequences of three phospholipases A (CM-I, CM-II and CM-III),” BBA - Protein Structure, vol. 493, no. 1, pp. 216–227, 1977. View at Publisher · View at Google Scholar · View at Scopus
  52. W. W. Lin, P. L. Chang, C. Y. Lee, and F. J. Joubert, “Pharmacological study on phospholipases A2 isolated from Naja mossambica mossambica venom,” Proceedings of the National Science Council, Republic of China, Part B, Life Sciences, vol. 11, no. 2, pp. 155–163, 1987. View at Google Scholar
  53. U. K. Ranawaka, D. G. Lalloo, H. J. de Silva, and J. White, “Neurotoxicity in snakebite—the limits of our knowledge,” PLOS Neglected Tropical Diseases, vol. 7, no. 10, Article ID e2302, 2013. View at Publisher · View at Google Scholar
  54. J. Pungerčar and I. Križaj, “Understanding the molecular mechanism underlying the presynaptic toxicity of secreted phospholipases A2,” Toxicon, vol. 50, no. 7, pp. 871–892, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Petan, I. Križaj, M. H. Gelb, and J. Pungerčar, “Ammodytoxins, potent presynaptic neurotoxins, are also highly efficient phospholipase A2 enzymes,” Biochemistry, vol. 44, no. 37, pp. 12535–12545, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. B. Lomonte and J. Rangel, “Snake venom Lys49 myotoxins: from phospholipases A2 to non-enzymatic membrane disruptors,” Toxicon, vol. 60, no. 4, pp. 520–530, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Otero, J. Gutiérrez, M. Beatriz Mesa et al., “Complications of Bothrops, Porthidium, and Bothriechis snakebites in Colombia. A clinical and epidemiological study of 39 cases attended in a university hospital,” Toxicon, vol. 40, no. 8, pp. 1107–1114, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. J. M. Gutiérrez and C. L. Ownby, “Skeletal muscle degeneration induced by venom phospholipases A2: insights into the mechanisms of local and systemic myotoxicity,” Toxicon, vol. 42, no. 8, pp. 915–931, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Milani Júnior, M. T. Jorge, F. P. Ferraz de Campos et al., “Snake bites by the jararacuçu (Bothrops jararacussu): clinicopathological studies of 29 proven cases in São Paulo State, Brazil,” QJM: An International Journal of Medicine, vol. 90, no. 5, pp. 323–334, 1997. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Montecucco, J. M. Gutiérrez, and B. Lomonte, “Cellular pathology induced by snake venom phospholipase A2 myotoxins and neurotoxins: common aspects of their mechanisms of action,” Cellular and Molecular Life Sciences, vol. 65, no. 18, pp. 2897–2912, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Lomonte and J. M. Gutierrez, “Phospholipases A2 from viperidae snake venoms: how do they induce skeletal muscle damage?” Acta Chimica Slovenica, vol. 58, no. 4, pp. 647–659, 2011. View at Google Scholar
  62. B. Lomonte, E. Moreno, A. Tarkowski, L. Å. Hanson, and M. Maccarana, “Neutralizing interaction between heparins and myotoxin II, a lysine 49 phospholipase A2 from Bothrops asper snake venom: identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling,” The Journal of Biological Chemistry, vol. 269, no. 47, pp. 29867–29873, 1994. View at Google Scholar · View at Scopus
  63. C. E. Núez, Y. Angulo, and B. Lomonte, “Identification of the myotoxic site of the Lys49 phospholipase A2 from Agkistrodon piscivorus piscivorus snake venom: Synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities,” Toxicon, vol. 39, no. 10, pp. 1587–1594, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. L. Chioato, E. A. Aragão, T. Lopes Ferreira, A. Ivo de Medeiros, L. H. Faccioli, and R. J. Ward, “Mapping of the structural determinants of artificial and biological membrane damaging activities of a Lys49 phospholipase A2 by scanning alanine mutagenesis,” Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 1768, no. 5, pp. 1247–1257, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. H. M. Verheij, M.-C. Boffa, C. Rothen, M. Bryckaert, R. Verger, and G. H. de Haas, “Correlation of Enzymatic Activity and Anticoagulant Properties of Phospholipase A2,” European Journal of Biochemistry, vol. 112, no. 1, pp. 25–32, 1980. View at Publisher · View at Google Scholar · View at Scopus
  66. R. M. Kini, “Anticoagulant proteins from snake venoms: Structure, function and mechanism,” Biochemical Journal, vol. 397, no. 3, pp. 377–387, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. D. Saikia, R. Thakur, and A. K. Mukherjee, “An acidic phospholipase A2 (RVVA-PLA2-I) purified from Daboia russelli venom exerts its anticoagulant activity by enzymatic hydrolysis of plasma phospholipids and by non-enzymatic inhibition of factor Xa in a phospholipids/Ca2+ independent manner,” Toxicon, vol. 57, no. 6, pp. 841–850, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Stefansson, R. M. Kini, and H. J. Evans, “The basic phospholipase A2 from Naja nigricollis venom inhibits the prothrombinase complex by a novel nonenzymatic mechanism,” Biochemistry, vol. 29, no. 33, pp. 7742–7746, 1990. View at Publisher · View at Google Scholar · View at Scopus
  69. R. P. Samy, P. Gopalakrishnakone, and V. T. Chow, “Therapeutic application of natural inhibitors against snake venom phospholipase A2,” Bioinformation, vol. 8, no. 1, pp. 48–57, 2012. View at Publisher · View at Google Scholar
  70. S. Marcussi, C. D. Sant'Ana, C. Z. Oliveira et al., “Snake venom phospholipase A2 inhibitors: Medicinal chemistry and therapeutic potential,” Current Topics in Medicinal Chemistry, vol. 7, no. 8, pp. 743–756, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. A. M. Soares, F. K. Ticli, S. Marcussi et al., “Medicinal plants with inhibitory properties against snake venoms,” Current Medicinal Chemistry, vol. 12, no. 22, pp. 2625–2641, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Deepa and T. Veerabasappa Gowda, “Purification and characterization of a glycoprotein inhibitor of toxic phospholipase from Withania somnifera,” Archives of Biochemistry and Biophysics, vol. 408, no. 1, pp. 42–50, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. L. Mishra, B. B. Singh, and S. Dagenais, “Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review,” Alternative Medicine Review, vol. 5, no. 4, pp. 334–346, 2000. View at Google Scholar · View at Scopus
  74. D. K. Machiah and T. V. Gowda, “Purification of a post-synaptic neurotoxic phospholipase A2 from Naja naja venom and its inhibition by a glycoprotein from Withania somnifera,” Biochimie, vol. 88, no. 6, pp. 701–710, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. M. H. Borges, A. M. Soares, V. M. Rodrigues et al., “Effects of aqueous extract of Casearia sylvestris (Flacourtiaceae) on actions of snake and bee venoms and on activity of phospholipases A2,” Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology, vol. 127, no. 1, pp. 21–30, 2000. View at Publisher · View at Google Scholar · View at Scopus
  76. M. H. Borges, A. M. Soares, V. M. Rodrigues et al., “Neutralization of proteases from Bothrops snake venoms by the aqueous extract from Casearia sylvestris (Flacourtiaceae),” Toxicon, vol. 39, no. 12, pp. 1863–1869, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. W. L. G. Cavalcante, T. O. Campos, M. Dal Pai-Silva et al., “Neutralization of snake venom phospholipase A2 toxins by aqueous extract of Casearia sylvestris (Flacourtiaceae) in mouse neuromuscular preparation,” Journal of Ethnopharmacology, vol. 112, no. 3, pp. 490–497, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. J. A. Pereañez, A. C. Patiño, V. Núñez, and E. Osorio, “The biflavonoid morelloflavone inhibits the enzymatic and biological activities of a snake venom phospholipase A2,” Chemico-Biological Interactions, vol. 220, pp. 94–101, 2014. View at Publisher · View at Google Scholar · View at Scopus
  79. C. A. Cotrim, S. C. B. De Oliveira, E. B. S. Diz Filho et al., “Quercetin as an inhibitor of snake venom secretory phospholipase A2,” Chemico-Biological Interactions, vol. 189, no. 1-2, pp. 9–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. C. F. Bennett, S. Mong, M. A. Clarke, L. I. Kruse, and S. T. Crooke, “Differential effects of manoalide on secreted and intracellular phospholipases,” Biochemical Pharmacology, vol. 36, no. 5, pp. 733–740, 1987. View at Publisher · View at Google Scholar · View at Scopus
  81. L. J. Reynolds, B. P. Morgan, G. A. Hite, E. D. Mihelich, and E. A. Dennis, “Phospholipase A2 inhibition and modification by manoalogue,” Journal of the American Chemical Society, vol. 110, no. 15, pp. 5172–5177, 1988. View at Publisher · View at Google Scholar · View at Scopus
  82. S. L. G. Rocha, B. Lomonte, A. G. C. Neves-Ferreira et al., “Functional analysis of DM64, an antimyotoxic protein with immunoglobulin-like structure from Didelphis marsupialis serum,” European Journal of Biochemistry, vol. 269, no. 24, pp. 6052–6062, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. I. R. León, A. G. da Costa Neves-Ferreira, S. L. G. da Rocha, M. R. de Oliveira Trugilho, J. Perales, and R. H. Valente, “Using mass spectrometry to explore the neglected glycan moieties of the antiophidic proteins DM43 and DM64,” Proteomics, vol. 12, no. 17, pp. 2753–2765, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. S. Lizano, G. Domont, and J. Perales, “Natural phospholipase A2 myotoxin inhibitor proteins from snakes, mammals and plants,” Toxicon, vol. 42, no. 8, pp. 963–977, 2003. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Quirós, A. Alape-Girón, Y. Angulo, and B. Lomonte, “Isolation, characterization and molecular cloning of AnMIP, a new α-type phospholipase A2 myotoxin inhibitor from the plasma of the snake Atropoides nummifer (Viperidae: Crotalinae),” Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology, vol. 146, no. 1, pp. 60–68, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. C. Z. Oliveira, N. A. Santos-Filho, D. L. Menaldo et al., “Structural and functional characterization of a γ-type phospholipase A 2 inhibitor from Bothrops jararacussu Snake Plasma,” Current Topics in Medicinal Chemistry, vol. 11, no. 20, pp. 2509–2519, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Lizano, B. Lomonte, J. W. Fox, and J. M. Gutiérrez, “Biochemical characterization and pharmacological properties of a phospholipase A2 myotoxin inhibitor from the plasma of the snake Bothrops asper,” Biochemical Journal, vol. 326, no. 3, pp. 853–859, 1997. View at Publisher · View at Google Scholar · View at Scopus
  88. N. Ohkura, H. Okuhara, S. Inoue, K. Ikeda, and K. Hayashi, “Purification and characterization of three distinct types of phospholipase A2 inhibitors from the blood plasma of the Chinese mamushi, Agkistrodon blomhoffii siniticus,” Biochemical Journal, vol. 325, no. 2, pp. 527–531, 1997. View at Publisher · View at Google Scholar · View at Scopus
  89. K. Chen, L.-P. Zhong, L.-Z. Chen, X. Li, X. Xu, and C.-H. Huang, “Investigation and purification of snake venom secretory phospholipase A2 inhibitors from sera of some common snake species in Jiangxi province,” Pharmaceutical Biotechnology, vol. 18, no. 3, pp. 220–223, 2011. View at Google Scholar · View at Scopus
  90. Z. Le, X. Li, P. Yuan, P. Liu, and C. Huang, “Orthogonal optimization of prokaryotic expression of a natural snake venom phospholipase A2 inhibitor from Sinonatrix annularis,” Toxicon, vol. 108, pp. 264–271, 2015. View at Publisher · View at Google Scholar · View at Scopus
  91. M. E. Garcia Denegri, S. Maruñak, J. S. Todaro, L. A. Ponce-Soto, O. Acosta, and L. Leiva, “Neutralisation of the pharmacological activities of Bothrops alternatus venom by anti-PLA2 IgGs,” Toxicon, vol. 86, pp. 89–95, 2014. View at Publisher · View at Google Scholar · View at Scopus
  92. J. P. Rodriguez, M. De Marzi, S. Maruñak, E. L. Malchiodi, L. C. Leiva, and O. Acosta, “Rabbit IgG antibodies against phospholipase A2 from Crotalus durissus terrificus neutralize the lethal activity of the venom,” Medicina, vol. 66, no. 6, pp. 512–516, 2006. View at Google Scholar · View at Scopus
  93. L. S. Fusco, J. P. Rodríguez, F. Torres-Huaco et al., “P9a(Cdt-PLA2) from Crotalus durissus terrificus as good immunogen to be employed in the production of crotalic anti-PLA2 IgG,” Toxicology Letters, vol. 238, no. 1, pp. 7–16, 2015. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Karakas and W. Koenig, “Varespladib methyl, an oral phospholipase A2 inhibitor for the potential treatment of coronary artery disease,” IDrugs, vol. 12, no. 9, pp. 585–592, 2009. View at Google Scholar · View at Scopus
  95. D. De Luca, A. Minucci, J. Trias et al., “Varespladib inhibits secretory phospholipase A2 in bronchoalveolar lavage of different types of neonatal lung injury,” Clinical Pharmacology and Therapeutics, vol. 52, no. 5, pp. 729–737, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. R. S. Rosenson, M. Elliott, Y. Stasiv, and C. Hislop, “Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease,” European Heart Journal, vol. 32, no. 8, pp. 999–1005, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. M. Lewin, S. Samuel, J. Merkel, and P. Bickler, “Varespladib (LY315920) appears to be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a possible pre-referral treatment for envenomation,” Toxins, vol. 8, no. 9, article no. 248, 2016. View at Publisher · View at Google Scholar · View at Scopus
  98. D. Mora-Obando, J. Fernández, C. Montecucco, J. M. Gutiérrez, and B. Lomonte, “Synergism between basic Asp49 and Lys49 phospholipase A2 myotoxins of viperid snake venom in vitro and in vivo,” PLoS ONE, vol. 9, no. 10, Article ID e109846, 2014. View at Publisher · View at Google Scholar · View at Scopus
  99. L. D. Possani, B. M. Martin, A. Yatani et al., “Isolation and physiological characterization of taicatoxin, a complex toxin with specific effects on calcium channels,” Toxicon, vol. 30, no. 11, pp. 1343–1364, 1992. View at Publisher · View at Google Scholar · View at Scopus
  100. S. Xiong, Y. Luo, L. Zhong et al., “Investigation of the inhibitory potential of phospholipase A2 inhibitor gamma from Sinonatrix annularis to snake envenomation,” Toxicon, vol. 137, pp. 83–91, 2017. View at Publisher · View at Google Scholar